Targeting of endothelial cells in brain tumours
Clinical and Translational Medicine · 2023-10 · 13 (10)
DOI: 10.1002/ctm2.1433 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Medicine, online erschienen am 13.10.2023. Verfasst von Wenzhe Duan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, The Second Hospital, Dalian Medical University, Dalian, China. Hauptthemen laut MEDLINE: Brain Neoplasms, Glioma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Liaoning Revitalization Talents Program.
Abstract (Originalsprache)
Background
Aggressive brain tumours, whether primary gliomas or secondary metastases, are characterised by hypervascularisation and are fatal. Recent research has emphasised the crucial involvement of endothelial cells (ECs) in all brain tumour genesis and development events, with various patterns and underlying mechanisms identified. Main body Here, we highlight recent advances in knowledge about the contributions of ECs to brain tumour development, providing a comprehensive summary including descriptions of interactions between ECs and tumour cells, the heterogeneity of ECs and new models for research on ECs in brain malignancies. We also discuss prospects for EC targeting in novel therapeutic approaches.
Conclusion
Interventions targeting ECs, as an adjunct to other therapies (e.g. immunotherapies, molecular‐targeted therapies), have shown promising clinical efficacy due to the high degree of vascularisation in brain tumours. Developing precise strategies to target tumour‐associated vessels based on the heterogeneity of ECs is expected to improve anti‐vascular efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Medicine, The Second Hospital, Dalian Medical University, Dalian, China.
- Cancer Translational Medicine Research Center, The Second Hospital, Dalian Medical University, Dalian, China.
ORCID-Profile: Qi Wang
Förderung
- National Natural Science Foundation of China
- Liaoning Revitalization Talents Program
Zitieren
APA
Duan, W., Xia, S., Tang, M., Lin, M., Liu, W., & Wang, Q. (2023). Targeting of endothelial cells in brain tumours. Clinical and Translational Medicine, 13(10). https://doi.org/10.1002/ctm2.1433
Vancouver
Duan W, Xia S, Tang M, Lin M, Liu W, Wang Q. Targeting of endothelial cells in brain tumours. Clinical and Translational Medicine. 2023;13(10). doi:10.1002/ctm2.1433
BibTeX
@article{Duan2023,
author = {Duan, Wenzhe and Xia, Shengkai and Tang, Mengyi and Lin, Manqing and Liu, Wenwen and Wang, Qi},
title = {Targeting of endothelial cells in brain tumours},
journal = {Clinical and Translational Medicine},
year = {2023},
volume = {13},
number = {10},
doi = {10.1002/ctm2.1433}
}
EUVIMED